NCT01672996

Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers

A Phase 1/2, Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Contrast-Enhanced Abdominal Computed Tomography in Healthy Volunteers

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: GE Healthcare · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

To optimize both the Ioforminol concentration and dosage(s) for CECT of the abdomen. To evaluate the safety and tolerability of low concentration Ioforminol Injections. Study recruits healthy volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Ioforminol 160 mgI/mL	Given as s single administration to the subject
DRUG	Ioforminol 200 mgI/mL	Given as a single administration to the subject
DRUG	Iopamidol 300 mgI/mL	Given as a single administration to the subject

Timeline

• Start date: 2012-07-01
• Primary completion: 2012-08-01
• Completion: 2012-08-01
• First posted: 2012-08-27
• Last updated: 2014-05-29
• Results posted: 2014-03-03

Locations

1 site across 1 country: United States